Stage 3 Mesothelioma News
- Lilly Acquires ImClone Systems In $6.5B Transaction Friday, October 10, 2008 @ 6:08AMEli Lilly and Company and ImClone Systems Inc. recently announced that the boards of directors of both companies have approved a definitive merger agreement under which Lilly will acquire ImClone through an all cash tender offer of $70.00 per share, or approximately $6.5B.
- Eli Lilly to buy ImClone for more than $6B Monday, October 6, 2008 @ 12:17PM(AP:INDIANAPOLIS) Eli Lilly & Co. has agreed to spend more than $6 billion to fortify its cancer treatment portfolio by acquiring the biotechnology firm ImClone Systems Inc. in a deal that tops earlier offers from competitor Bristol-Myers Squibb Co.
- Lilly To Buy ImClone Monday, October 6, 2008 @ 10:32AMIndianapolis-based drug-maker Eli Lilly & Co. says it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand its pipeline of cancer treatments.
- Eli Lilly agrees to buy ImClone for over $6B Monday, October 6, 2008 @ 9:28AMNEW YORK - The drugmaker Eli Lilly & Co. said Monday it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand its pipeline of cancer treatments.
- Eli Lilly agrees to buy ImClone for over $6B Monday, October 6, 2008 @ 9:19AMThe drugmaker Eli Lilly & Co. said Monday it has agreed to buy biotechnology company ImClone Systems Inc. for more than $6 billion in a deal that would expand its pipeline of cancer treatments. New York-based ImClone had previously rejected as too low two lower-priced takeover offers from Bristol-Myers Squibb Co., its marketing partner for the cancer drug Erbitux. Indianapolis-based Lilly said ...
- Lilly to acquire ImClone Monday, October 6, 2008 @ 9:09AMLilly expects the $6 billion deal would expand its pipeline of cancer treatments.
- Eli Lilly agrees to buy ImClone for over $6B Monday, October 6, 2008 @ 8:54AMNEW YORK - The drugmaker Eli Lilly & Co. said Monday it has agreed to buy biotechnology company ImClone Systems Inc. for more than US$6 billion in a deal that would expand its pipeline of cancer treatments.
- Eli Lilly to buy ImClone for more than $6B Monday, October 6, 2008 @ 8:34AMEli Lilly & Co. has agreed to spend more than $6 billion to fortify its cancer treatment portfolio by acquiring the biotechnology firm ImClone Systems Inc. in a deal that tops earlier offers from competitor Bristol-Myers Squibb Co. Indianapols-based Lilly announced Monday that it will pay $70 per share for ImClone. New York-based Bristol-Myers then said it would not increase its latest offer ...
- HOME PAGE Friday, June 6, 2008 @ 1:54PMRupee, Sensex move in tandem on volatile day When stocks rise, bonds normally fall (yields rise) and when stocks fall, bonds rise (yields fall).This is a typical market scenario.Where foreign investments are permitted in a country’s financial markets, there is the currency ...
- Yuma volunteers sought for cancer research study Thursday, April 10, 2008 @ 2:13AMThe lifestyles and behaviors of 300 Yuma-area residents who volunteer to mail in surveys could give researchers clues into the causes and prevention of cancer for future generations.
